Evidence-Based Medicine Guidelines
Transdermal fentanyl for cancer pain
Transdermal fentanyl for cancer pain is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transdermal Fentanyl for Cancer Pain." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain.
Transdermal fentanyl for cancer pain. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain. Accessed March 29, 2023.
Transdermal fentanyl for cancer pain. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain
Transdermal Fentanyl for Cancer Pain [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transdermal fentanyl for cancer pain
ID - 458185
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
